Bio-Sourcing

Bio-Sourcing is a private, pre-revenue biotech company leveraging a breakthrough platform that combines CRISPR-Cas9 gene editing, nuclear transfer, and reproductive technologies to produce biopharmaceuticals in goat milk. This approach promises to drastically reduce capital costs and production expenses while increasing scalability, targeting the global unmet need for affordable monoclonal antibodies. The company, led by an experienced team of scientists, positions its technology as a solution for both Western and emerging economies to improve access to biologics, particularly during pandemics.

Proprietary platform using CRISPR-Cas9 gene editing, nuclear transfer, and reproductive technologies to produce fully human biopharmaceuticals (e.g., monoclonal antibodies) in the milk of genetically engineered goats.

Competes with traditional mammalian cell culture (dominant) and other next-generation production systems like plant-based (e.g., BioApp), microbial, and continuous cell culture platforms. Must demonstrate clear cost, scale, and quality advantages to displace incumbents.